Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: Review and reappraisal

Pediatric Infectious Disease Journal

Volumn 16, Issue 9, 1997, Pages 885-894

  Hoppe, Jörg E ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Candida albicans; Candidal diaper dermatitis; Oropharyngeal candidiasis; Treatment

Indexed keywords

AMPHOTERICIN B; CRYSTAL VIOLET; NYSTATIN;

ANTIFUNGAL ACTIVITY; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPER DERMATITIS; DISEASE CONTROL; DISEASE TRANSMISSION; HUMAN; INFANT; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; THRUSH;

ANTIFUNGAL AGENTS; CANDIDIASIS, CUTANEOUS; CANDIDIASIS, ORAL; CLINICAL TRIALS; DERMATITIS; DIAPER RASH; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OROPHARYNX; PROGNOSIS;

EID: 0030848768     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199709000-00013     Document Type: Review

References (72)

1. Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am 1988;35: 543-63.
2. Baley JE. Neonatal candidiasis: the current challenge. Clin Perinatol 1991;18:263-80.
3. Alban J, Groel JT. Amphotericin B oral suspension in the treatment of thrush. Curr Ther Res 1970;12:479-84.
4. Huang NN, High RH. Treatment of oral moniliasis in infants and children with nystatin. In: Monographs on therapy. vol 2. New Brunswick, NJ: Squibb Institute for Medical Research, 1957:60-6.
5. Huang NN, Sarria A, High RH. Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants and children. Antibiot Annu 1957-1958. 1958:59-64.
6. Kozinn PJ, Taschdjian CL, Dragutsky D, Minsky A. Therapy of oral thrush: a comparative evaluation of gentian violet, mycostatin, and amphotericin B. In: Monographs on therapy. vol 2. New Brunswick, NJ: Squibb Institute for Medical Research, 1957:16-24.
7. Dobias B. Moniliasis in pediatrics. Am J Dis Child 1957;94: 234-51.
8. Mintz AA, Tengg NE. The management of oral moniliasis (thrush) in a pediatric clinic. Clin Med 1965;72:992-1000.
9. Hughes WT. Candidiasis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:1907-16.
10. Kozinn PJ, Taschdjian CL, Wiener H, Dragutsky D, Minsky A. Neonatal candidiasis. Pediatr Clin North Am 1960;5:803-15.
11. Harris LJ, Pritzker HG, Laski B, Eisen A, Steiner JW, Shack L. The effect of nystatin (Mycostatin) on neonatal candidiasis (thrush). Can Med Assoc J 1958;79:891-6.
12. Fitzpatrick RE, Newcomer VD. Candidiasis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:805-16.
13. Jennison RF. Thrush in infancy. Arch Dis Child 1977;52: 747-9.
14. Anderson NA, Sage DN, Spaulding EH. Oral moniliasis in newborn infants. Am J Dis Child 1944;67:450-6.
15. Schwarze R, Blaschke-Hellmessen R, Hinkel GK, Hoffmann H, Weigl I. Untersuchungen zur Soorprophylaxe Neugeborener. Kinderarztl Prax 1976;44:305-14.
16. Epstein B. Studien zur Soorkrankheit. Jahrb Kinderheilkd 1924;104:129-82.
17. Kozinn PJ, Taschdjian CL, Wiener H. Incidence and pathogenesis of neonatal candidiasis. Pediatrics 1958;21:421-9.
18. Russell C, Lay KM. Natural history of Candida species and yeasts in the oral cavity of infants. Arch Oral Biol 1973;18: 957-62.
19. Taschdjian CL, Kozinn PJ. Laboratory and clinical studies on candidiasis in the newborn infant. J Pediatr 1957;50:426-33.
20. Kozinn PJ, Taschdjian CL, Dragutsky D, Minsky A. Cutaneous candidiasis in early infancy and childhood. Pediatrics 1957;20:827-34.
21. Dhondt F, Ninane J, De Beule K, Dhondt A, Cauwenbergh G. Oral candidosis: treatment with absorbable and non-absorbable antifungal agents in children. Mycoses 1992;35: 1-8.
22. Hughes WT. Persistent thrush in young infants [Letter]. Pediatr Infect Dis J 1987;11:1074-5.
23. Faber HK, Dickey LB. The treatment of thrush with gentian violet. JAMA 1925;85:900-1.
24. Leung AKC. Gentian violet in the treatment of oral candidiasis [Letter]. Pediatr Infect Dis J 1988;7:304-5.
25. Drinkwater P. Gentian violet: is it safe? Aust NZ J Obstet Gynaecol 1990;30:65-6.
26. Dobias B, Hazen EL. Nystatin. Chemotherapia 1961;3:108-19.
27. Witten VH, Katz SI. Nystatin. Med Clin North Am 1970;54: 1329-37.
28. Brunner R. Nystatin. In: Brunner R, ed. Die Antibiotika. vol. 2. Nürnberg, Germany: H. Carl, 1965:594-617.
29. Schwarze R, Blaschke-Hellmessen R, Pappisch M. Orale Applikation von Nystatin und Amphotericin B zur Prophylaxe und Therapie von Candidamykosen bei Risikoneugeborenen. In: Sitzmann FC, ed. Infektionen mit Parasiten und Pilzen im Kindesalter. Munich, Germany: H. Marseille, 1995: 199-210.
30. Hamra LK, Pankiewicz IJ. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine. Med J Aust 1977;2:749-50.
31. Bergan T, Vangdal M. In vitro activity of antifungal agents against yeast species. Chemotherapy 1983;29:104-10.
32. Blaschke-Hellmessen R, Schwarze U. Bioassay for determination of nystatin in faeces after oral application. Mycoses 1990;33:129-35.
33. Blaschke-Hellmessen R, Buchmann H, Schwarze R. Einfluss oral verabreichter Polyenantimykotika auf die Hefepilzbesiedlung des Darmtraktes: Möglichkeiten und Grenzen. Mycoses 1996;39(Suppl 1):33-9.
34. Blaschke-Hellmessen R, Pannwitz U, Schwarze R. Zur intestinalen Ausscheidung von Nystatin während und nach oraler Applikation bei Risikoneugeborenen. Monatsschr Kinderheilkd 1991;139:89-91.
35. Boon JM, Lafeber HN, t'Mannetje AH, et al. Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis. Mycoses 1989;32: 312-5.
36. Mansour A, Gelfand EW. A new approach to the use of antifungal agents in infants with persistent oral candidiasis. J Pediatr 1981;98:161-2.
37. Hoppe JE, Hahn H, Antimycotics Study Group. Randomized comparison of two nystatin oral gels with miconazole oral gel for treatment of oral thrush in infants. Infection 1996;24: 136-9.
38. Blaschke-Hellmessen R, Schwarze R. Amphotericin-B-Spiegel in Faeces und Serum während oraler Verabreichung bei Risikoneugeborenen. Mycoses 1994;37(Suppl 1):84-8.
39. Hofstra W, de Vries-Hospers HG, van der Waaij D. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses. Infection 1982;10:223-7.
40. Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs 1975;9:406-23.
41. Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS. Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs 1980;19:7-30.
42. Van Cutsem JM, Thienpont D. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy 1972;17:392-404.
43. Data on file. Beerse, Belgium: Janssen Pharmaceuticals, 1976.
44. Brugmans J, van Cutsem J, Heykants J, Schuermans V, Thienpont D. Systemic antifungal potential, safety, biotransport and transformation of miconazole nitrate. Eur J Clin Pharmacol 1972;5:93-9.
45. Casneuf J, de Loore F, Dhondt F, et al. Oral thrush in children treated with miconazole gel. Mykosen 1980;23:75-8.
46. Reading JH, Clifford PD, Coles RW, Rajagopalan N. An open assessment of miconazole oral gel in the treatment of paediatric oral candidosis in general practice. Curr Ther Res 1981;30:605-10.
47. Freitag V, Schumacher G, Sternowsky HJ. Soor im Mund- und Windelbereich: Behandlung mit Miconazol oder Nystatin. Kinderarzt 1983;14:177-8.
48. Schaad UB, Bachmann D. Prospektiver Vergleich von Miconazol-Gel und Nystatin-Suspension in der Therapie des Mundsoors. Schweiz Med Wochenschr 1983;113:1356-62.
49. Hoppe JE, Antifungals Study Group. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. Pediatr Infect Dis J 1997;16:288-93.
50. Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs 1975;9:424-47.
51. Grossman ER. Treatment of thrush [Letter]. Pediatr Infect Dis J 1988;7:303.
52. Hoppe JE, Moosmann K. Vergleich von Miconazol-Gel und Nystatin-Hydroxyethylcellulose-Gel zur Behandlung des Mundsoors bei Säuglingen. Monatsschr Kinderheilkd 1994; 142:285-7.
53. Ibrahim J. Über eine Soormykose der Haut im frühen Säuglingsalter. Arch Kinderheilkd 1911;55:91-101.
54. Rebora A, Leyden JJ. Napkin (diaper) dermatitis and gastrointestinal carriage of Candida albicans. Br J Dermatol 1981; 105:551-5.
55. Holzel A. Skin thrush in early infancy. Arch Dis Child 1953;28:412-5.
56. Bound JP. Thrush napkin rashes. Br Med J 1956;1:782-4.
57. Leyden JJ, Kligman AM. The role of microorganisms in diaper dermatitis. Arch Dermatol 1978;114:56-9.
58. Swift S. Diaper dermatitis. Pediatr Clin North Am 1956;3: 759-69.
59. Rebora A, Marples RR, Kligman AM. Experimental infection with Candida albicans. Arch Dermatol 1973;108:69-73.
60. Jacobs AH. Eruptions in the diaper area. Pediatr Clin North Am 1978;25:209-24.
61. Alban J. Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants. Curr Ther Res 1972;14:158-61.
62. Kozinn PJ, Taschdjian CL, Burchall JJ, Wiener H. Comparative effectiveness of antibiotic dusting powders in candidal and non-candidal diaper rashes. Antibiot Annu 1958-1959. 1959:910-3.
63. Dobias B. Treatment of cutaneous moniliasis in pediatrics with nystatin. In: Monographs on therapy, vol 2. New Brunswick, NJ: Squibb Institute for Medical Research, 1957:49-54.
64. Kozinn PJ, Taschdjian CL, Dragutsky D, Minsky A. Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B. Antibiot Annu 1956-1957. 1957:128-34.
65. Stritzler C. Cutaneous candidiasis treated with topical amphotericin B. Arch Dermatol 1966;93:101-5.
66. MacKie RM, Scott E. Topical miconazole cream in infantile napkin dermatitis. Practitioner 1979;222:124-6.
67. Bowring ARW, Mackay D, Taylor FR. The treatment of napkin dermatitis: a double-blind comparison of two steroid-antibiotic combinations. Pharmatherapeutica 1984;3:613-7.
68. Vanheule R, Adriaensen K, de Hauwere R, van Cutsem J, de Cree J. Prevalence and treatment with miconazole of fungal skin infections in children and premature infants. Castellania 1974;2:91-2.
69. Dixon PN, Warin RP, English MP. Alimentary Candida albicans and napkin rashes. Br J Dermatol 1972;86:458-62.
70. Munz D, Powell KR, Pai CH. Treatment of candidal diaper dermatitis: a double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin. J Pediatr 1982;101:1022-5.
71. Buchner SJ. Persistent thrush in young infants [Letter]. Pediatr Infect Dis J 1987;11:1074-5.
72. Wainer S, Cooper PA, Funk E, Bental RY, Sandler DA, Patel J. Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection. Pediatr Infect Dis J 1992;11:713-6.